Company Filing History:
Years Active: 2003-2010
Title: The Innovations of Stuart Tugendreich
Introduction
Stuart Tugendreich is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of biotechnology, holding a total of 8 patents. His work primarily focuses on methods and apparatuses that enhance the understanding of biological responses in subjects.
Latest Patents
Among his latest patents is the invention related to Peroxisome proliferation activated receptor alpha (PPARα) signatures. This invention includes methods for rapid testing and predicting a PPARα response, which is similar to the effects of PPARα agonists. The invention comprises a PPARα response signature that includes a set of twenty genes. It also discloses methods for using the differential expression of these genes to predict whether a compound will induce a PPARα response in a test subject. Another significant patent is the cholesterol reduction signature, which provides methods and compositions for rapidly testing or predicting the propensity of a test compound to induce cholesterol reduction in a subject. This invention also includes a cholesterol reduction signature and the method for deriving it.
Career Highlights
Stuart Tugendreich has worked with several prominent companies in the biotechnology sector. He has been associated with Iconix Pharmaceuticals, Inc. and Entelos, Inc., where he has contributed to various innovative projects. His expertise in the field has allowed him to develop groundbreaking technologies that have the potential to impact health and wellness.
Collaborations
Throughout his career, Tugendreich has collaborated with notable professionals, including Dongxu Sun and Edward Perkins. These collaborations have further enriched his work and contributed to the advancement of his inventions.
Conclusion
Stuart Tugendreich's contributions to biotechnology through his patents and collaborations highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to pave the way for future developments in the field.